MENU
MNKD
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
MannKind (MNKD) Earnings Date & Reports
MannKind Corp is a biopharmaceutical company dedicated to transforming chronic disease care through patient-centric solutions... Show more
Industry: #Biotechnology
A.I. Advisor
published Earnings
MNKD is expected to report earnings to rise 463.00% to -5 cents per share on November 10
Q3'26
Est.
$-0.06
Q2'26
Est.
$-0.01
Q1'26
Missed
by $0.01
Q4'25
Missed
by $0.01
Q3'25
Beat
by $0.05
The last earnings report on August 05 showed earnings per share of 0 cents, meeting the estimate of 0 cents. With 212.56K shares outstanding, the current market capitalization sits at 977.50M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Interesting Articles
A.I. Advisor
published General Information
General Information
a developer of therapeutic products
Industry Biotechnology
Industry
Biotechnology
Address
1 Casper Street
Phone
+1 818 661-5000
Employees
592
Web
https://www.mannkindcorp.com